2000
DOI: 10.7326/0003-4819-132-8-200004180-00009
|View full text |Cite
|
Sign up to set email alerts
|

The Lyme Disease Vaccine: Conception, Development, and Implementation

Abstract: In the past 20 years, remarkable strides have been made toward understanding and preventing Lyme disease in humans. In December 1998, the U.S. Food and Drug Administration approved a recombinant outer surface protein A vaccine against Lyme disease (LYMErix, SmithKline Beecham, Philadelphia, Pennsylvania). The vaccine, which is derived from a lipidated outer surface protein of the causative spirochete Borrelia burgdorferi, is important because it may decrease the morbidity and financial costs associated with Ly… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
21
0
1

Year Published

2001
2001
2016
2016

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 55 publications
(22 citation statements)
references
References 60 publications
0
21
0
1
Order By: Relevance
“…OspA is mainly expressed while the spirochetes persist in the tick and the expression of OspA is already down-regulated when the pathogen is transmitted to the human host. The OspA vaccine leads to a 70 -90% protection (10,11,13). On the other hand, OspC is preferentially expressed in the mammalian host.…”
mentioning
confidence: 99%
“…OspA is mainly expressed while the spirochetes persist in the tick and the expression of OspA is already down-regulated when the pathogen is transmitted to the human host. The OspA vaccine leads to a 70 -90% protection (10,11,13). On the other hand, OspC is preferentially expressed in the mammalian host.…”
mentioning
confidence: 99%
“…Effective vaccines containing OMPs have been developed for Lyme disease and pertussis (7,17,23,47,49). Several characteristics should be considered when evaluating an OMP as a vaccine candidate, including expression of the protein on the bacterial surface during human infection, conservation of the protein among strains, and the ability to induce a protective immune response (9, 18).…”
mentioning
confidence: 99%
“…On few occasions, inoculation may occur earlier if spirochetes are already present in the salivary glands of the infected tick (Alekseev et al, 1995). Though, for proper B. burgdorferi transmission to occur an infected tick must attach for at least 24 hours on the animal (Thanassi & Schoen 2000), its transmission to the host has been seen to occur as early as 18 hours after attachment (Alekseev et al, 1995). Concurrent infection with other tick-borne pathogens like Anaplasma phagocytophilum (Persing 1997) and Theileria equi (Basile et al, 2015) can occur.…”
Section: Pathophysiologymentioning
confidence: 99%